COLUMBIA, Md., May 29 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference in New York. The conference is being held June 11 - 12, 2008 at the New York Palace Hotel. Peter L. Buzy, CFO is scheduled to present on Thursday, June 12, 2008 at 1:30 p.m. Eastern Time.
A live audio webcast of Martek's presentation can be accessed at: http://www.wsw.com/webcast/needham25/matk/
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.
Contact: Kyle Stults
|SOURCE Martek Biosciences Corporation|
Copyright©2008 PR Newswire.
All rights reserved